Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201

Sachiko Yamamoto,Hisato Kawakami,Takayuki Kii,Hiroki Hara,Ryohei Kawabata,Junji Kawada,Atsushi Takeno,Jin Matsuyama,Shugo Ueda,Yoshihiro Okita,Shunji Endo,Yutaka Kimura, Kazuhiro Yanagihara,Tatsuya Okuno,Yukinori Kurokawa ,Toshio Shimokawa,Taroh Satoh

European Journal of Cancer 154 (2021) 307-315